Mandana Hasanzad

932 total citations
70 papers, 545 citations indexed

About

Mandana Hasanzad is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Mandana Hasanzad has authored 70 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 12 papers in Surgery. Recurrent topics in Mandana Hasanzad's work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Mandana Hasanzad is often cited by papers focused on Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Mandana Hasanzad collaborates with scholars based in Iran, United States and Greece. Mandana Hasanzad's co-authors include Negar Sarhangi, Hamid Reza Aghaei Meybodi, Bagher Larijani, Mahdi Afshari, Shekoufeh Nikfar, Fatemeh Rouhollah, Fatemeh Khatami, Farshad Sharifi, Ali Akbar Haghdoost and Nazli Khodayari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Life Sciences.

In The Last Decade

Mandana Hasanzad

63 papers receiving 532 citations

Peers

Mandana Hasanzad

GENET

EDM

SURGE

Nadezhda Glezeva Ireland

Michael S. Balzer Germany

Hannah C. Ainsworth United States

Emmanuel Lazaridis United States

Jijia Hu China

Chris Carlson United States

Ming Ta Michael Lee United States

Amy Damask United States

Horațiu Silaghi Romania

Eriko Sumi Japan

Nadezhda Glezeva Ireland

Mandana Hasanzad

313 ×1.3

46 ×0.5

GENET

129 ×1.5

56 ×0.7

EDM

100 ×1.3

SURGE

Citations per year, relative to Mandana Hasanzad Mandana Hasanzad (= 1×) peers Nadezhda Glezeva

Countries citing papers authored by Mandana Hasanzad

Since Specialization

Citations

This map shows the geographic impact of Mandana Hasanzad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandana Hasanzad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandana Hasanzad more than expected).

Fields of papers citing papers by Mandana Hasanzad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandana Hasanzad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandana Hasanzad. The network helps show where Mandana Hasanzad may publish in the future.

Co-authorship network of co-authors of Mandana Hasanzad

This figure shows the co-authorship network connecting the top 25 collaborators of Mandana Hasanzad. A scholar is included among the top collaborators of Mandana Hasanzad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandana Hasanzad. Mandana Hasanzad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasanzad, Mandana, et al.. (2025). Proposed method for economic evaluation based on basket trials: a case study of pembrolizumab. Expert Review of Pharmacoeconomics & Outcomes Research. 25(10). 1401–1410. 1 indexed citations

Afshari, Mahdi, et al.. (2024). Association of common single-nucleotide polymorphism of HHEX with type 2 diabetes mellitus. Journal of Diabetes & Metabolic Disorders. 23(1). 1183–1187. 2 indexed citations

Hasanzad, Mandana, et al.. (2024). Cost-Effectiveness Analysis of Pharmacogenomics-Guided Versus Standard Dosing of Warfarin in Patients with Mechanical Prosthetic Heart Valve. Iranian journal of pharmaceutical research. 23(1). e143898–e143898. 1 indexed citations

Sharifi, Farshad, et al.. (2023). Association of ABCC8 gene variants with response to sulfonylurea in type 2 diabetes mellitus. Journal of Diabetes & Metabolic Disorders. 22(1). 649–655. 2 indexed citations

Hasanzad, Mandana, et al.. (2023). Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis. Value in Health Regional Issues. 37. 71–80. 5 indexed citations

Sheikhy, Ali, Mandana Hasanzad, Shekoufeh Nikfar, Kaveh Hosseini, & Masih Tajdini. (2022). Role of personalized medicine in cardiovascular disease: A narrative review. SHILAP Revista de lepidopterología. 1 indexed citations

Sarhangi, Negar, et al.. (2022). Effects of the TCF7L2 and KCNQ1 common variant on sulfonylurea response in type 2 diabetes mellitus patients: a preliminary pharmacogenetic study. Journal of Diabetes & Metabolic Disorders. 21(1). 133–139. 1 indexed citations

Gholami, Morteza, et al.. (2022). Haplotypic variants of COVID‐19 related genes are associated with blood pressure and metabolites levels. Journal of Medical Virology. 95(1). e28355–e28355. 2 indexed citations

Sheikhy, Ali, Aida Fallahzadeh, Hamid Reza Aghaei Meybodi, et al.. (2021). Personalized medicine in cardiovascular disease: review of literature. Journal of Diabetes & Metabolic Disorders. 20(2). 1793–1805. 9 indexed citations

10.

Hasanzad, Mandana, et al.. (2021). Pilot study in pharmacogenomic management of empagliflozin in type 2 diabetes mellitus patients. Journal of Diabetes & Metabolic Disorders. 20(2). 1407–1413. 1 indexed citations

11.

Sarhangi, Negar, Shekoufeh Nikfar, Mandana Hasanzad, & Bagher Larijani. (2021). Precision medicine path at personalized medicine research center/endocrinology and metabolism research institute: A systematic review. Journal of Diabetes & Metabolic Disorders. 23(2). 1507–1513. 1 indexed citations

12.

Sarhangi, Negar, et al.. (2020). MTNR1B common genetic variant is associated with type 2 diabetes mellitus risk. Gene Reports. 20. 100695–100695. 2 indexed citations

13.

Khatami, Fatemeh, Bagher Larijani, Shekoufeh Nikfar, et al.. (2019). <p>Personalized treatment options for thyroid cancer: current perspectives</p>. Pharmacogenomics and Personalized Medicine. Volume 12. 235–245. 18 indexed citations

14.

Hasanzad, Mandana, et al.. (2019). The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers. Journal of Gastrointestinal Cancer. 51(2). 591–599. 6 indexed citations

15.

Tourzani, Zahra Mehdizadeh, et al.. (2017). Health Education in Gestational Diabetes Mellitus and Quality of Life. SHILAP Revista de lepidopterología. 9 indexed citations

16.

Hasanzad, Mandana, et al.. (2014). Genetic polymorphism of endothelial nitric oxide synthase in coronary artery disease. 2. 1 indexed citations

17.

Hasanzad, Mandana, et al.. (2012). Analysis of endothelial nitric oxide synthase (eNOS) gene polymorphism Glu 298 Asp as a risk factor of coronary artery disease in a sample of Iranian population. Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch. 22(2). 116–121. 1 indexed citations

18.

Hasanzad, Mandana, et al.. (2012). Association of Angiotensin I Converting Enzyme Polymorphism as Genetic Risk Factor in Benign Prostatic Hyperplasia and Prostate Cancer. Genetic Testing and Molecular Biomarkers. 16(7). 770–774. 9 indexed citations

19.

Kahrizi, Kimia, et al.. (2010). Genotype–Phenotype Correlations in Iranian Myotonic Dystrophy Type I Patients. SHILAP Revista de lepidopterología. 1 indexed citations

20.

Hasanzad, Mandana, et al.. (2009). Carrier frequency of SMA by quantitative analysis of the SMN1 deletion in the Iranian population. European Journal of Neurology. 17(1). 160–162. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact